Skip to content

Incidence of posterior capsular opacifiaction after intraocular lens implantation in pediatric and juvenile cataract

Incidence of posterior capsular opacifiaction after intraocular lens implantation in pediatric and juvenile cataract - --

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00023736
Enrollment
80
Registered
2020-11-27
Start date
2020-12-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

H26.0 H26.1

Interventions

Group 1: Cross-sectional check-up of recipients of bag-in-the-lens (BIL) intraocular lens implantation. Assessment includes: Refraction, best corrected visual acuity, intraocular pressure, biometry, c

Sponsors

Universitätsklinikum Freiburg
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients who have received phacoemulsification and intraocular lens implantation surgery since January 1, 2000 and who had not yet reached the age of 14 years at the time of surgery. At least 6 months must have passed between the time of surgery and the last examination.

Exclusion criteria

Exclusion criteria: Congenital Glaucoma Corneal Disease Microphthalmus (axis length < 17 mm) Anterior segment dysgenesis Other severe ocular or systemic malformation

Design outcomes

Primary

MeasureTime frame
Time until relevant visual axis opacification in the operated eye

Secondary

MeasureTime frame
Time until peripheral visual axis opacification (without visual impairment) Influence of the type of intraocular lens (brand, model, material), influence of the biometric device used and the biometric formula, complications (especially secondary cataract, nystagmus, glaucoma, cystoid macular edema, detachment of the retina, eccentrically positioned IOL), characterization of the patient population (age, sex, relevant previous diseases and treatments, etc.), deviation from the target refraction, biometric error

Countries

Germany

Contacts

Public ContactWolf Lagrèze

Universitätsklinikum Freiburg, Klinik Für Augenheilkunde, Sektion NKS

wolf.lagreze@uniklinik-freiburg.de076127040010

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026